familymednews.com
Individual regions of the brain have to team up to get things done. And like in any team, the key to working together is communication. Duke researchers used brain imaging to identify how patterns of brain connectivity—the ability of different brain regions to talk to each other—can affect a person’s likelihood of developing common forms of mental illness. Surprisingly, they […]
Continue reading »
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers. In experiments described in the May 11 issue of the journal Circulation […]
Continue reading »
Psychology researchers have used the game League of Legends to advance our understanding of how people build “mental models—the mental tools that allow people to make use of complex systems. The researchers found that mental models are developed in three distinct stages—findings that have the potential to inform everything from workplace training to video-game development. “We create mental models to […]
Continue reading »
Jean-François Côté, a researcher at the Montreal Clinical Research Institute (IRCM) and professor at Université de Montréal’s Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the development of metastases in an aggressive type of cancer, HER2-positive breast cancer. One in eight women will be diagnosed with […]
Continue reading »
Hospitals caring for children with serious, chronic illness are highly dependent on public payers, according to a new study. The research found that proposals to dramatically reduce federal expenditures on Medicaid and Children’s Health Insurance Program (CHIP) could destabilize current specialty care referral networks serving all children, including the majority of privately-insured children in greatest need of high quality, specialized, […]
Continue reading »
(HealthDay)—Among patients with coronary heart disease without severe systolic dysfunction, sudden and/or arrhythmic deaths (SAD) account for a considerable proportion of deaths, according to a study published online May 2 in JAMA Cardiology. Neal A. Chatterjee, M.D., from Brigham and Women’s Hospital in Boston, and colleagues conducted a cohort study involving 135 clinical sites with 5,761 participants with coronary heart […]
Continue reading »
A study from City, University of London has found that time spent in a virtual world called EVA Park can improve the communication skills of people with aphasia, a communication condition which results in loss of speech and difficulty with communication following a stroke. The new findings from the study also show that EVA Park users frequently experience laughter and […]
Continue reading »
Alzheimer’s disease destroys brain cells in part by promoting the formation of insoluble clumps that contain a protein called tau. Not only are these “tau aggregates” toxic for the cells that harbor them, but they also invade and destroy neighboring brain cells, or neurons, which speeds the cognitive decline associated with the Alzheimer’s. For those reasons, Alzheimer’s researchers have been […]
Continue reading »
Against the backdrop of increasing antibiotic resistance, the FORMAMP project has trialled nanotechnology-based delivery systems and antimicrobial peptides (AMPs), to deliver new tools in the fight against infectious diseases. It has been calculated that increased microbial resistance is responsible for an estimated 25 000 deaths per year, costing EUR 1.5 billion, across the EU. In the quest for new therapies […]
Continue reading »
The treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo project has developed methods to improve drug delivery to tumours and improve the efficacy of anticancer therapy. Drug delivery to tumours is difficult. The blood vessels they depend on are abnormally structured, heterogeneously distributed and relatively poorly […]
Continue reading »